Board Meeting4 Nov 2026, 05:52 pm
Dipna Pharmachem Board Approves Standalone Unaudited Financial Results
AI Summary
Dipna Pharmachem Limited announced that its Board of Directors, in a meeting held on November 4, 2026, approved the Standalone Unaudited Financial Results for the quarter ended June 30, 2026. The meeting commenced at 5:00 PM and concluded at 5:30 PM at the company's registered office in Ahmedabad. A limited review report was also approved. The company has adopted IND AS from April 1, 2025, with a transition date of April 1, 2024.
Key Highlights
- Board meeting held on November 4, 2026.
- Standalone Unaudited Financial Results for Q1 FY27 approved.
- Limited Review Report also approved by the Board.
- Company adopted IND AS from April 1, 2025.
- No reportable segments as per AS-17.
Price Impact
More from DPL